JCAP Q1 2026: Revenue up 14% to $176M, but net income falls 41% on IPO costs and litigation

Filed May 14, 2026 · Period ending March 31, 2026 · ~1 min read

Key Changes

• high

  Net income dropped 41% to $37.6M despite 14% revenue growth, driven by $8.5M in IPO-related stock compensation and $8M in upfront court costs for consumer litigation.

  MD&A: Net Income & Operating Expenses verify on EDGAR →
• high

  Collections grew 19% to $309.9M, fueled by prior deployments including $54.5M from the Bluestem portfolio acquisition, signaling strong cash generation momentum.

  MD&A: Collections Growth verify on EDGAR →
• high

  Deployments fell 15% to $149.7M as U.S. purchases declined 26%, partially offset by 930% surge in Latin America; average purchase price compressed to 5.5% of face value.

  MD&A: Deployments verify on EDGAR →